Akr1c2 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AKR1C2 mRNA] | CTD | PMID:31150632 |
Akr1c2 | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:1353901 | 6480464 | epigallocatechin gallate results in increased expression of AKR1C2 mRNA | CTD | PMID:32512070 |
Akr1c2 | Rat | (20S)-20-hydroxypregn-4-en-3-one | increases chemical synthesis | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased chemical synthesis of 20-alpha-Dihydroprogesterone | CTD | PMID:11158055 |
Akr1c2 | Rat | (E)-cinnamyl alcohol | increases activity | ISO | RGD:1353901 | 6480464 | cinnamyl alcohol results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | RGD:1353901 | 6480464 | o,p'-DDT results in increased expression of AKR1C2 mRNA | CTD | PMID:18204070 |
Akr1c2 | Rat | 1,10-phenanthroline | decreases activity | ISO | RGD:1353901 | 6480464 | 1,10-phenanthroline results in decreased activity of AKR1C2 protein | CTD | PMID:12604236 |
Akr1c2 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1323510 | 6480464 | 1,2-Dimethylhydrazine results in increased expression of AKR1C21 mRNA | CTD | PMID:22206623 |
Akr1c2 | Rat | 1,3-benzothiazole-2-thiol | increases activity | ISO | RGD:1353901 | 6480464 | captax results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | 1,3-benzothiazole-2-thiol | increases expression | ISO | RGD:1353901 | 6480464 | captax results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607|PMID:20713136 |
Akr1c2 | Rat | 1,4-benzoquinone | increases expression | ISO | RGD:1353901 | 6480464 | quinone results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | 1,4-phenylenediamine | increases activity | ISO | RGD:1353901 | 6480464 | 4-phenylenediamine results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | 1,4-phenylenediamine | increases expression | ISO | RGD:1353901 | 6480464 | 4-phenylenediamine results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607|PMID:25724174 |
Akr1c2 | Rat | 1-chloro-2,4-dinitrobenzene | increases activity | ISO | RGD:1353901 | 6480464 | Dinitrochlorobenzene results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:1353901 | 6480464 | Dinitrochlorobenzene results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607|PMID:20713136 |
Akr1c2 | Rat | 1-phenyl-1,2-propanedione | increases expression | ISO | RGD:1353901 | 6480464 | 1-phenyl-1,2-propanedione results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1323510 | 6480464 | Ethinyl Estradiol affects the expression of AKR1C21 mRNA | CTD | PMID:17555576 |
Akr1c2 | Rat | 17beta-estradiol | increases expression | ISO | RGD:1353901 | 6480464 | Estradiol results in increased expression of AKR1C2 mRNA | CTD | PMID:19619570 |
Akr1c2 | Rat | 17beta-estradiol | multiple interactions | ISO | RGD:1353901 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AKR1C2 mRNA | CTD | PMID:19619570 |
Akr1c2 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased metabolism of and results in decreased activity of Dihydrotestosterone; Flufenamic more ... | CTD | PMID:14672942|PMID:17170221 |
Akr1c2 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases metabolic processing | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased metabolism of Dihydrotestosterone | CTD | PMID:14672942|PMID:22245609 |
Akr1c2 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of Dihydrotestosterone | CTD | PMID:11158055 |
Akr1c2 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:1353901 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:1353901 | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of AKR1C2 mRNA | CTD | PMID:25305463 |
Akr1c2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1353901 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AKR1C2 mRNA | CTD | PMID:19619570 |
Akr1c2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1353901 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AKR1C2 mRNA | CTD | PMID:19619570 |
Akr1c2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:1353901 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of AKR1C2 mRNA | CTD | PMID:25724174 |
Akr1c2 | Rat | 2,6-dimethoxyphenol | multiple interactions | ISO | RGD:1353901 | 6480464 | [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of AKR1C2 protein | CTD | PMID:38598786 |
Akr1c2 | Rat | 2-(chloromethyl)pyridine | increases expression | ISO | RGD:1353901 | 6480464 | 2-chloromethylpyridine results in increased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | 2-aminophenol | increases expression | ISO | RGD:1353901 | 6480464 | 2-aminophenol results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | 2-hexenal | increases expression | ISO | RGD:1353901 | 6480464 | 2-hexenal results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | 2-hydroxyethyl methacrylate | increases expression | ISO | RGD:1353901 | 6480464 | hydroxyethyl methacrylate results in increased expression of AKR1C2 mRNA | CTD | PMID:30497689 |
Akr1c2 | Rat | 2-palmitoylglycerol | increases expression | ISO | RGD:1353901 | 6480464 | 2-palmitoylglycerol results in increased expression of AKR1C2 mRNA | CTD | PMID:37199045 |
Akr1c2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased more ... | CTD | PMID:30744511 |
Akr1c2 | Rat | 3,3',5-triiodo-L-thyronine | increases expression | ISO | RGD:1353901 | 6480464 | Triiodothyronine results in increased expression of AKR1C2 mRNA | CTD | PMID:15507505 |
Akr1c2 | Rat | 3,4,5,3',4',5'-Hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased more ... | CTD | PMID:30744511 |
Akr1c2 | Rat | 3,4-dichloroaniline | increases expression | ISO | RGD:1353901 | 6480464 | 3,4-dichloroaniline results in increased expression of AKR1C2 mRNA | CTD | PMID:24172598 |
Akr1c2 | Rat | 3-Nitrobenzanthrone | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of 3-nitrobenzanthrone | CTD | PMID:30406992 |
Akr1c2 | Rat | 3-Nitrobenzanthrone | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein results in increased reduction of 3-nitrobenzanthrone] which results in increased chemical synthesis of more ... | CTD | PMID:30406992 |
Akr1c2 | Rat | 3-phenylprop-2-enal | increases activity | ISO | RGD:1353901 | 6480464 | cinnamaldehyde results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | RGD:1353901 | 6480464 | NFE2L2 mRNA promotes the reaction [cinnamaldehyde results in increased expression of AKR1C2 mRNA] | CTD | PMID:26244607 |
Akr1c2 | Rat | 3-phenylprop-2-enal | increases expression | ISO | RGD:1353901 | 6480464 | cinnamaldehyde results in increased expression of AKR1C2 mRNA | CTD | PMID:25724174|PMID:26244607 |
Akr1c2 | Rat | 3alpha-hydroxy-5beta-pregnan-20-one | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of Pregnanolone | CTD | PMID:11995921 |
Akr1c2 | Rat | 3alpha-hydroxy-5beta-pregnan-20-one | affects metabolic processing | ISO | RGD:1353901 | 6480464 | AKR1C2 protein affects the metabolism of Pregnanolone | CTD | PMID:12604236 |
Akr1c2 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1323510 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of AKR1C21 mRNA | CTD | PMID:18648102 |
Akr1c2 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | RGD:1353901 | 6480464 | bisphenol S results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1353901 | 6480464 | bisphenol S results in increased expression of AKR1C2 protein | CTD | PMID:34186270 |
Akr1c2 | Rat | 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases activity | ISO | RGD:1353901 | 6480464 | Oxazolone results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases metabolic processing | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CTD | PMID:11306090 |
Akr1c2 | Rat | 4-hydroxybenzoic acid | decreases activity | ISO | RGD:1353901 | 6480464 | 4-hydroxybenzoic acid analog results in decreased activity of AKR1C2 protein | CTD | PMID:27163852 |
Akr1c2 | Rat | 4-nitro-1,2-phenylenediamine | increases expression | ISO | RGD:1353901 | 6480464 | 1,2-diamino-4-nitrobenzene results in increased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | 4-nitrobenzyl bromide | increases activity | ISO | RGD:1353901 | 6480464 | 4-nitrobenzyl bromide results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | 4-nitrobenzyl bromide | increases expression | ISO | RGD:1353901 | 6480464 | 4-nitrobenzyl bromide results in increased expression of AKR1C2 mRNA | CTD | PMID:25724174 |
Akr1c2 | Rat | 5-alpha-THDOC | affects oxidation | ISO | RGD:1353901 | 6480464 | AKR1C2 protein affects the oxidation of tetrahydrodeoxycorticosterone | CTD | PMID:12604236 |
Akr1c2 | Rat | 5-fluorouracil | affects response to substance | ISO | RGD:1353901 | 6480464 | AKR1C2 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 |
Akr1c2 | Rat | 5alpha-pregnane-3,20-dione | affects reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein affects the reduction of 5-alpha-Dihydroprogesterone | CTD | PMID:12604236 |
Akr1c2 | Rat | 5alpha-pregnane-3,20-dione | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of 5-alpha-Dihydroprogesterone | CTD | PMID:11995921 |
Akr1c2 | Rat | 9,10-phenanthroquinone | increases metabolic processing | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased metabolism of 9,10-phenanthrenequinone | CTD | PMID:17950253 |
Akr1c2 | Rat | 9,10-phenanthroquinone | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of 9,10-phenanthrenequinone | CTD | PMID:21851338|PMID:23261716 |
Akr1c2 | Rat | 9,10-phenanthroquinone | multiple interactions | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of and affects the activity of 9,10-phenanthrenequinone | CTD | PMID:21910479 |
Akr1c2 | Rat | acetylsalicylic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Aspirin results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |
Akr1c2 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of AKR1C2 mRNA | CTD | PMID:28959563 |
Akr1c2 | Rat | actinomycin D | multiple interactions | ISO | RGD:1353901 | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of AKR1C2 protein | CTD | PMID:38460933 |
Akr1c2 | Rat | adefovir pivoxil | decreases expression | ISO | RGD:1353901 | 6480464 | adefovir dipivoxil results in decreased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | aflatoxin B1 | decreases methylation | ISO | RGD:1353901 | 6480464 | Aflatoxin B1 results in decreased methylation of AKR1C2 gene | CTD | PMID:27153756 |
Akr1c2 | Rat | ampicillin | decreases expression | ISO | RGD:1353901 | 6480464 | Ampicillin results in decreased expression of AKR1C2 mRNA | CTD | PMID:21632981 |
Akr1c2 | Rat | androstane-3,17-diol | increases chemical synthesis | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased chemical synthesis of Androstane-3,17-diol | CTD | PMID:11158055|PMID:17170221 |
Akr1c2 | Rat | arsane | multiple interactions | ISO | RGD:1353901 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C2 more ... | CTD | PMID:32525701 |
Akr1c2 | Rat | arsane | increases expression | ISO | RGD:1353901 | 6480464 | Arsenic results in increased expression of AKR1C2 mRNA | CTD | PMID:36861143 |
Akr1c2 | Rat | arsenic atom | multiple interactions | ISO | RGD:1353901 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C2 more ... | CTD | PMID:32525701 |
Akr1c2 | Rat | arsenic atom | increases expression | ISO | RGD:1353901 | 6480464 | Arsenic results in increased expression of AKR1C2 mRNA | CTD | PMID:36861143 |
Akr1c2 | Rat | arsenous acid | decreases response to substance | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Akr1c2 | Rat | arsenous acid | increases expression | ISO | RGD:1353901 | 6480464 | Arsenic Trioxide results in increased expression of AKR1C2 mRNA | CTD | PMID:21461292|PMID:26705709 |
Akr1c2 | Rat | arsenous acid | multiple interactions | ISO | RGD:1353901 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C2 protein] | CTD | PMID:26598702 |
Akr1c2 | Rat | avobenzone | increases expression | ISO | RGD:1353901 | 6480464 | avobenzone results in increased expression of AKR1C2 mRNA | CTD | PMID:31016361 |
Akr1c2 | Rat | azathioprine | increases expression | ISO | RGD:1353901 | 6480464 | Azathioprine results in increased expression of AKR1C2 mRNA | CTD | PMID:22623647|PMID:26198647 |
Akr1c2 | Rat | benzbromarone | decreases activity | ISO | RGD:1353901 | 6480464 | Benzbromarone results in decreased activity of AKR1C2 protein | CTD | PMID:12604236 |
Akr1c2 | Rat | benzo[a]pyrene | affects response to substance | ISO | RGD:1353901 | 6480464 | AKR1C2 protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:19800895 |
Akr1c2 | Rat | benzo[a]pyrene | affects methylation | ISO | RGD:1353901 | 6480464 | Benzo(a)pyrene affects the methylation of AKR1C2 promoter | CTD | PMID:27901495 |
Akr1c2 | Rat | benzo[a]pyrene | increases expression | ISO | RGD:1353901 | 6480464 | Benzo(a)pyrene results in increased expression of AKR1C2 mRNA | CTD | PMID:15735009|PMID:16545412|PMID:19800895|PMID:20106945|PMID:21632981|PMID:26198647 |
Akr1c2 | Rat | benzo[a]pyrene | multiple interactions | ISO | RGD:1323510 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Benzo(a)pyrene co-treated with Particulate Matter] results in increased expression of AKR1C21 more ... | CTD | PMID:18353537 |
Akr1c2 | Rat | benzo[a]pyrene | multiple interactions | ISO | RGD:1353901 | 6480464 | [Particulate Matter co-treated with Benzo(a)pyrene] results in increased expression of AKR1C2 mRNA; [Vehicle Emissions co-treated more ... | CTD | PMID:17612574|PMID:19800895 |
Akr1c2 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | RGD:1353901 | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of AKR1C2 mRNA | CTD | PMID:19150397 |
Akr1c2 | Rat | Benzo[a]pyrene-7,8-diol | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein co-treated with NADP] results in increased oxidation of and affects the activity of more ... | CTD | PMID:21910479 |
Akr1c2 | Rat | benzo[a]pyrene-7,8-dione | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein co-treated with NADP] results in increased reduction of and affects the activity of more ... | CTD | PMID:21910479 |
Akr1c2 | Rat | benzyl cinnamate | increases expression | ISO | RGD:1353901 | 6480464 | benzyl cinnamate results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | beta-lapachone | increases expression | ISO | RGD:1353901 | 6480464 | beta-lapachone results in increased expression of AKR1C2 mRNA | CTD | PMID:38218311 |
Akr1c2 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1353901 | 6480464 | Diethylhexyl Phthalate results in increased expression of AKR1C2 mRNA | CTD | PMID:28412506 |
Akr1c2 | Rat | bisphenol A | affects expression | ISO | RGD:1353901 | 6480464 | bisphenol A affects the expression of AKR1C2 mRNA | CTD | PMID:30903817 |
Akr1c2 | Rat | bisphenol A | decreases methylation | ISO | RGD:1353901 | 6480464 | bisphenol A results in decreased methylation of AKR1C2 gene | CTD | PMID:31601247 |
Akr1c2 | Rat | bisphenol A | decreases expression | ISO | RGD:1353901 | 6480464 | bisphenol A results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of AKR1C2 mRNA | CTD | PMID:30903817 |
Akr1c2 | Rat | bisphenol AF | increases expression | ISO | RGD:1353901 | 6480464 | bisphenol AF results in increased expression of AKR1C2 protein | CTD | PMID:34186270 |
Akr1c2 | Rat | Bisphenol B | increases expression | ISO | RGD:1353901 | 6480464 | bisphenol B results in increased expression of AKR1C2 protein | CTD | PMID:34186270 |
Akr1c2 | Rat | bisphenol F | decreases expression | ISO | RGD:1353901 | 6480464 | bisphenol F results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | bisphenol F | increases expression | ISO | RGD:1353901 | 6480464 | bisphenol F results in increased expression of AKR1C2 protein | CTD | PMID:34186270 |
Akr1c2 | Rat | bortezomib | affects expression | ISO | RGD:1353901 | 6480464 | Bortezomib affects the expression of AKR1C2 mRNA | CTD | PMID:21215737 |
Akr1c2 | Rat | cadmium atom | increases expression | ISO | RGD:1353901 | 6480464 | Cadmium results in increased expression of AKR1C2 mRNA | CTD | PMID:21120746|PMID:21172416 |
Akr1c2 | Rat | cadmium atom | multiple interactions | ISO | RGD:1353901 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR1C2 more ... | CTD | PMID:29741670 |
Akr1c2 | Rat | cadmium dichloride | affects expression | ISO | RGD:1353901 | 6480464 | Cadmium Chloride affects the expression of AKR1C2 mRNA | CTD | PMID:23828170 |
Akr1c2 | Rat | cadmium dichloride | multiple interactions | ISO | RGD:1353901 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR1C2 more ... | CTD | PMID:29741670 |
Akr1c2 | Rat | cadmium dichloride | increases expression | ISO | RGD:1353901 | 6480464 | Cadmium Chloride results in increased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | cadmium sulfate | multiple interactions | ISO | RGD:1353901 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of more ... | CTD | PMID:18654764 |
Akr1c2 | Rat | celastrol | increases expression | ISO | RGD:1353901 | 6480464 | celastrol results in increased expression of AKR1C2 mRNA | CTD | PMID:17010675 |
Akr1c2 | Rat | chenodeoxycholic acid | affects binding | ISO | RGD:1353901 | 6480464 | Chenodeoxycholic Acid binds to AKR1C2 protein | CTD | PMID:8486699 |
Akr1c2 | Rat | chenodeoxycholic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Chenodeoxycholic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:8573067 |
Akr1c2 | Rat | chlorambucil | decreases expression | ISO | RGD:1353901 | 6480464 | Chlorambucil results in decreased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | chloroacetaldehyde | increases expression | ISO | RGD:1353901 | 6480464 | chloroacetaldehyde results in increased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | chlorohydrocarbon | multiple interactions | EXP | | 6480464 | [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of more ... | CTD | PMID:30744511 |
Akr1c2 | Rat | chloromethylisothiazolinone | increases activity | ISO | RGD:1353901 | 6480464 | 5-chloro-2-methyl-4-isothiazolin-3-one results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | chloropicrin | affects expression | ISO | RGD:1353901 | 6480464 | chloropicrin affects the expression of AKR1C2 mRNA | CTD | PMID:26352163 |
Akr1c2 | Rat | chloropicrin | increases expression | ISO | RGD:1353901 | 6480464 | chloropicrin results in increased expression of AKR1C2 mRNA | CTD | PMID:28476498 |
Akr1c2 | Rat | cidofovir anhydrous | affects expression | ISO | RGD:1353901 | 6480464 | Cidofovir affects the expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | ciglitazone | multiple interactions | ISO | RGD:1353901 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C2 mRNA; more ... | CTD | PMID:16197558 |
Akr1c2 | Rat | cinnamyl alcohol | increases activity | ISO | RGD:1353901 | 6480464 | cinnamyl alcohol results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | cisplatin | decreases response to substance | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in decreased susceptibility to Cisplatin | CTD | PMID:20953859 |
Akr1c2 | Rat | cisplatin | multiple interactions | ISO | RGD:1353901 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of AKR1C2 mRNA | CTD | PMID:27392435 |
Akr1c2 | Rat | cisplatin | decreases expression | ISO | RGD:1353901 | 6480464 | Cisplatin results in decreased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | cisplatin | increases expression | ISO | RGD:1353901 | 6480464 | Cisplatin results in increased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | citral | increases expression | ISO | RGD:1353901 | 6480464 | citral results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | citral | increases activity | ISO | RGD:1353901 | 6480464 | citral results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | clodronic acid | increases expression | ISO | RGD:1353901 | 6480464 | Clodronic Acid results in increased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | Clofop | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of fenofibric acid | CTD | PMID:27599626 |
Akr1c2 | Rat | cloxazolam | decreases activity | ISO | RGD:1353901 | 6480464 | cloxazolam results in decreased activity of AKR1C2 protein | CTD | PMID:12604236 |
Akr1c2 | Rat | cobalt dichloride | multiple interactions | ISO | RGD:1353901 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of more ... | CTD | PMID:18654764 |
Akr1c2 | Rat | coniferyl aldehyde | increases expression | ISO | RGD:1353901 | 6480464 | coniferaldehyde results in increased expression of AKR1C2 mRNA; coniferaldehyde results in increased expression of AKR1C2 more ... | CTD | PMID:26275128 |
Akr1c2 | Rat | copper atom | multiple interactions | ISO | RGD:1353901 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1C2 mRNA | CTD | PMID:20971185 |
Akr1c2 | Rat | copper(0) | multiple interactions | ISO | RGD:1353901 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1C2 mRNA | CTD | PMID:20971185 |
Akr1c2 | Rat | copper(II) chloride | increases expression | ISO | RGD:1353901 | 6480464 | cupric chloride results in increased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | crocidolite asbestos | decreases expression | ISO | RGD:1353901 | 6480464 | Asbestos, Crocidolite results in decreased expression of AKR1C2 mRNA | CTD | PMID:18687144 |
Akr1c2 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of AKR1C2 mRNA | CTD | PMID:26577399 |
Akr1c2 | Rat | cyclopentanol | increases oxidation | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased oxidation of cyclopentanol | CTD | PMID:23261716 |
Akr1c2 | Rat | cyclopentanone | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of cyclopentanone | CTD | PMID:23261716 |
Akr1c2 | Rat | cyclopentanone | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein co-treated with NADP] results in increased reduction of cyclopentanone; NADP promotes the reaction more ... | CTD | PMID:23261716 |
Akr1c2 | Rat | cyclosporin A | increases expression | ISO | RGD:1353901 | 6480464 | Cyclosporine results in increased expression of AKR1C2 mRNA | CTD | PMID:22147139|PMID:25562108|PMID:25596134 |
Akr1c2 | Rat | DDE | decreases expression | ISO | RGD:1353901 | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | diarsenic trioxide | increases expression | ISO | RGD:1353901 | 6480464 | Arsenic Trioxide results in increased expression of AKR1C2 mRNA | CTD | PMID:21461292|PMID:26705709 |
Akr1c2 | Rat | diarsenic trioxide | multiple interactions | ISO | RGD:1353901 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C2 protein] | CTD | PMID:26598702 |
Akr1c2 | Rat | diarsenic trioxide | decreases response to substance | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Akr1c2 | Rat | diazepam | decreases activity | ISO | RGD:1353901 | 6480464 | Diazepam results in decreased activity of AKR1C2 protein | CTD | PMID:11995921|PMID:12604236 |
Akr1c2 | Rat | dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:1353901 | 6480464 | [Particulate Matter co-treated with dibenzo(a,l)pyrene] results in increased expression of AKR1C2 mRNA; [Vehicle Emissions co-treated more ... | CTD | PMID:17612574 |
Akr1c2 | Rat | dienogest | decreases expression | ISO | RGD:1353901 | 6480464 | dienogest results in decreased expression of AKR1C2 mRNA | CTD | PMID:23183084 |
Akr1c2 | Rat | diethyl maleate | increases expression | ISO | RGD:1353901 | 6480464 | diethyl maleate results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | diethyl sulfate | increases expression | ISO | RGD:1353901 | 6480464 | diethyl sulfate results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | dioxygen | decreases expression | ISO | RGD:1353901 | 6480464 | Oxygen deficiency results in decreased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | RGD:1353901 | 6480464 | Antimony Potassium Tartrate results in increased expression of AKR1C2 protein | CTD | PMID:28713220 |
Akr1c2 | Rat | diquat | increases expression | ISO | RGD:1353901 | 6480464 | Diquat results in increased expression of AKR1C2 mRNA | CTD | PMID:21172416 |
Akr1c2 | Rat | diuron | increases expression | ISO | RGD:1353901 | 6480464 | Diuron metabolite results in increased expression of AKR1C2 mRNA | CTD | PMID:24172598 |
Akr1c2 | Rat | dorsomorphin | multiple interactions | ISO | RGD:1353901 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Akr1c2 | Rat | doxorubicin | decreases expression | ISO | RGD:1353901 | 6480464 | Doxorubicin results in decreased expression of AKR1C2 mRNA | CTD | PMID:29803840 |
Akr1c2 | Rat | dutasteride | increases expression | ISO | RGD:1353901 | 6480464 | Dutasteride results in increased expression of AKR1C2 mRNA | CTD | PMID:16806904 |
Akr1c2 | Rat | dydrogesterone | decreases activity | ISO | RGD:1353901 | 6480464 | Dydrogesterone results in decreased activity of AKR1C2 protein | CTD | PMID:22245609 |
Akr1c2 | Rat | dydrogesterone | decreases expression | ISO | RGD:1353901 | 6480464 | Dydrogesterone results in decreased expression of AKR1C2 mRNA | CTD | PMID:23183084 |
Akr1c2 | Rat | entinostat | decreases expression | ISO | RGD:1353901 | 6480464 | entinostat results in decreased expression of AKR1C2 mRNA | CTD | PMID:27188386 |
Akr1c2 | Rat | epoxiconazole | increases expression | ISO | RGD:1323510 | 6480464 | epoxiconazole results in increased expression of AKR1C21 mRNA | CTD | PMID:35436446 |
Akr1c2 | Rat | estazolam | decreases activity | ISO | RGD:1353901 | 6480464 | Estazolam results in decreased activity of AKR1C2 protein | CTD | PMID:11995921 |
Akr1c2 | Rat | Ethyl acrylate | increases expression | ISO | RGD:1353901 | 6480464 | ethyl acrylate results in increased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | ethyl methanesulfonate | increases expression | ISO | RGD:1353901 | 6480464 | Ethyl Methanesulfonate results in increased expression of AKR1C2 mRNA | CTD | PMID:23649840 |
Akr1c2 | Rat | ethylene glycol dimethacrylate | increases activity | ISO | RGD:1353901 | 6480464 | ethylene dimethacrylate results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | ethylparaben | increases expression | ISO | RGD:1353901 | 6480464 | ethyl-p-hydroxybenzoate results in increased expression of AKR1C2 mRNA | CTD | PMID:37690743 |
Akr1c2 | Rat | eugenol | increases expression | ISO | RGD:1353901 | 6480464 | Eugenol results in increased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | farnesal | increases expression | ISO | RGD:1353901 | 6480464 | farnesal results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | fenamic acid | decreases activity | ISO | RGD:1353901 | 6480464 | fenamic acid analog results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |
Akr1c2 | Rat | fenofibrate | increases expression | ISO | RGD:1353901 | 6480464 | Fenofibrate results in increased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | flufenamic acid | multiple interactions | ISO | RGD:1353901 | 6480464 | Flufenamic Acid inhibits the reaction [AKR1C2 protein results in increased metabolism of Dihydrotestosterone] | CTD | PMID:14672942 |
Akr1c2 | Rat | flufenamic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Flufenamic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:12604236|PMID:8573067 |
Akr1c2 | Rat | flunitrazepam | decreases activity | ISO | RGD:1353901 | 6480464 | Flunitrazepam results in decreased activity of AKR1C2 protein | CTD | PMID:11995921 |
Akr1c2 | Rat | fluorescein 5-isothiocyanate | increases expression | ISO | RGD:1353901 | 6480464 | Fluorescein-5-isothiocyanate results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | flurbiprofen | decreases activity | ISO | RGD:1353901 | 6480464 | Flurbiprofen results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |
Akr1c2 | Rat | folic acid | increases expression | ISO | RGD:1323510 | 6480464 | Folic Acid results in increased expression of AKR1C21 mRNA | CTD | PMID:25629700 |
Akr1c2 | Rat | formaldehyde | increases expression | ISO | RGD:1353901 | 6480464 | Formaldehyde results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607|PMID:20655997 |
Akr1c2 | Rat | furfural | multiple interactions | ISO | RGD:1353901 | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of AKR1C2 protein; [Sodium Chloride co-treated more ... | CTD | PMID:38598786 |
Akr1c2 | Rat | gedunin | increases expression | ISO | RGD:1353901 | 6480464 | gedunin results in increased expression of AKR1C2 mRNA | CTD | PMID:17010675 |
Akr1c2 | Rat | geranial | increases expression | ISO | RGD:1353901 | 6480464 | citral results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | geranial | increases activity | ISO | RGD:1353901 | 6480464 | citral results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | glipizide | decreases activity | ISO | RGD:1353901 | 6480464 | Glipizide results in decreased activity of AKR1C2 protein | CTD | PMID:26362498 |
Akr1c2 | Rat | glyburide | decreases activity | ISO | RGD:1353901 | 6480464 | Glyburide results in decreased activity of AKR1C2 protein | CTD | PMID:26362498 |
Akr1c2 | Rat | glycyrrhetinate | decreases activity | ISO | RGD:1353901 | 6480464 | Glycyrrhetinic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:12604236 |
Akr1c2 | Rat | glycyrrhetinic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Glycyrrhetinic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:12604236 |
Akr1c2 | Rat | glyoxal | increases activity | ISO | RGD:1353901 | 6480464 | Glyoxal results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | glyoxal | increases expression | ISO | RGD:1353901 | 6480464 | Glyoxal results in increased expression of AKR1C2 mRNA | CTD | PMID:25724174 |
Akr1c2 | Rat | gold atom | increases expression | ISO | RGD:1353901 | 6480464 | Gold results in increased expression of AKR1C2 mRNA | CTD | PMID:29705079 |
Akr1c2 | Rat | gold(0) | increases expression | ISO | RGD:1353901 | 6480464 | Gold results in increased expression of AKR1C2 mRNA | CTD | PMID:29705079 |
Akr1c2 | Rat | hexestrol | decreases activity | ISO | RGD:1353901 | 6480464 | Hexestrol results in decreased activity of AKR1C2 protein | CTD | PMID:12604236|PMID:8573067 |
Akr1c2 | Rat | hydralazine | multiple interactions | ISO | RGD:1353901 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA | CTD | PMID:17183730 |
Akr1c2 | Rat | hydrogen peroxide | increases expression | ISO | RGD:1353901 | 6480464 | Hydrogen Peroxide results in increased expression of AKR1C2 mRNA | CTD | PMID:12414654 |
Akr1c2 | Rat | hydrogen peroxide | affects expression | ISO | RGD:1353901 | 6480464 | Hydrogen Peroxide affects the expression of AKR1C2 mRNA | CTD | PMID:23410634 |
Akr1c2 | Rat | hydrogen peroxide | multiple interactions | ISO | RGD:1353901 | 6480464 | [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression more ... | CTD | PMID:19320734 |
Akr1c2 | Rat | ibuprofen | decreases activity | ISO | RGD:1353901 | 6480464 | Ibuprofen results in decreased activity of AKR1C2 protein | CTD | PMID:19010312|PMID:8573067 |
Akr1c2 | Rat | ifosfamide | increases expression | ISO | RGD:1353901 | 6480464 | Ifosfamide results in increased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | imidurea | increases activity | ISO | RGD:1353901 | 6480464 | imidazolidinyl urea results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | indometacin | decreases activity | ISO | RGD:1353901 | 6480464 | Indomethacin results in decreased activity of AKR1C2 protein | CTD | PMID:12604236|PMID:19010312|PMID:8573067 |
Akr1c2 | Rat | isoeugenol | increases expression | ISO | RGD:1353901 | 6480464 | isoeugenol results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | isoeugenol | increases activity | ISO | RGD:1353901 | 6480464 | isoeugenol results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | ivermectin | decreases expression | ISO | RGD:1353901 | 6480464 | Ivermectin results in decreased expression of AKR1C2 protein | CTD | PMID:32959892 |
Akr1c2 | Rat | L-ascorbic acid | increases expression | ISO | RGD:1353901 | 6480464 | Ascorbic Acid results in increased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | lead diacetate | increases expression | ISO | RGD:1353901 | 6480464 | lead acetate results in increased expression of AKR1C2 mRNA | CTD | PMID:22839698|PMID:38568856 |
Akr1c2 | Rat | lead diacetate | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of AKR1C2 more ... | CTD | PMID:39276841 |
Akr1c2 | Rat | lead(0) | affects splicing | ISO | RGD:1353901 | 6480464 | Lead affects the splicing of AKR1C2 mRNA | CTD | PMID:28903495 |
Akr1c2 | Rat | lead(0) | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of AKR1C2 more ... | CTD | PMID:39276841 |
Akr1c2 | Rat | lead(II) chloride | multiple interactions | ISO | RGD:1353901 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of more ... | CTD | PMID:18654764 |
Akr1c2 | Rat | lead(II) chloride | increases expression | ISO | RGD:1353901 | 6480464 | lead chloride results in increased expression of AKR1C2 mRNA | CTD | PMID:18654764 |
Akr1c2 | Rat | linalool | increases expression | ISO | RGD:1353901 | 6480464 | linalool results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | lithocholic acid | affects binding | ISO | RGD:1353901 | 6480464 | AKR1C2 protein binds to Lithocholic Acid; Lithocholic Acid binds to AKR1C2 protein | CTD | PMID:8486699|PMID:8573067 |
Akr1c2 | Rat | lithocholic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Lithocholic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:12604236|PMID:8573067 |
Akr1c2 | Rat | LY294002 | multiple interactions | ISO | RGD:1353901 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [panaxytriol results in increased activity of AKR1C2 protein] | CTD | PMID:18826220 |
Akr1c2 | Rat | malathion | increases expression | ISO | RGD:1353901 | 6480464 | Malathion results in increased expression of AKR1C2 mRNA | CTD | PMID:16079077 |
Akr1c2 | Rat | meclofenamic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Meclofenamic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:19010312|PMID:26362498|PMID:27163852 |
Akr1c2 | Rat | Medazepam | decreases activity | ISO | RGD:1353901 | 6480464 | Medazepam results in decreased activity of AKR1C2 protein | CTD | PMID:11995921|PMID:12604236 |
Akr1c2 | Rat | medroxyprogesterone acetate | decreases activity | ISO | RGD:1353901 | 6480464 | Medroxyprogesterone Acetate results in decreased activity of AKR1C2 protein | CTD | PMID:12604236|PMID:22245609 |
Akr1c2 | Rat | mefenamic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Mefenamic Acid analog results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |
Akr1c2 | Rat | menadione | increases expression | ISO | RGD:1353901 | 6480464 | Vitamin K 3 results in increased expression of AKR1C2 mRNA | CTD | PMID:12414654|PMID:23410634 |
Akr1c2 | Rat | mercury dibromide | increases expression | ISO | RGD:1353901 | 6480464 | mercuric bromide results in increased expression of AKR1C2 mRNA | CTD | PMID:26272509 |
Akr1c2 | Rat | mercury dibromide | multiple interactions | ISO | RGD:1353901 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Akr1c2 | Rat | mercury dichloride | increases expression | ISO | RGD:1353901 | 6480464 | Mercuric Chloride results in increased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | methyl methanesulfonate | increases expression | ISO | RGD:1353901 | 6480464 | Methyl Methanesulfonate results in increased expression of AKR1C2 mRNA | CTD | PMID:23649840 |
Akr1c2 | Rat | methyl non-2-ynoate | increases expression | ISO | RGD:1353901 | 6480464 | 2-nonynoic acid methyl ester results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | methylmercury chloride | increases expression | ISO | RGD:1353901 | 6480464 | methylmercuric chloride results in increased expression of AKR1C2 mRNA | CTD | PMID:28001369 |
Akr1c2 | Rat | methylmercury chloride | multiple interactions | EXP | | 6480464 | [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of more ... | CTD | PMID:30744511 |
Akr1c2 | Rat | methylparaben | decreases expression | ISO | RGD:1353901 | 6480464 | methylparaben results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | n-propyl gallate | increases expression | ISO | RGD:1353901 | 6480464 | Propyl Gallate results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | NAD zwitterion | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein co-treated with NAD] results in increased oxidation of acenaphthene-1-ol; dichloro(4-cymene)ruthenium(II) analog inhibits the more ... | CTD | PMID:25446855 |
Akr1c2 | Rat | NAD(+) | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein co-treated with NAD] results in increased oxidation of acenaphthene-1-ol; dichloro(4-cymene)ruthenium(II) analog inhibits the more ... | CTD | PMID:25446855 |
Akr1c2 | Rat | NADP zwitterion | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein co-treated with NADP] results in increased oxidation of and affects the activity of more ... | CTD | PMID:14672942|PMID:21910479|PMID:23261716 |
Akr1c2 | Rat | NADP(+) | multiple interactions | ISO | RGD:1353901 | 6480464 | [AKR1C2 protein co-treated with NADP] results in increased oxidation of and affects the activity of more ... | CTD | PMID:14672942|PMID:21910479|PMID:23261716 |
Akr1c2 | Rat | naphthalenes | multiple interactions | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of and affects the activity of Naphthalenes | CTD | PMID:21910479 |
Akr1c2 | Rat | naproxen | decreases activity | ISO | RGD:1353901 | 6480464 | Naproxen results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |
Akr1c2 | Rat | nitrazepam | decreases activity | ISO | RGD:1353901 | 6480464 | Nitrazepam results in decreased activity of AKR1C2 protein | CTD | PMID:11995921 |
Akr1c2 | Rat | Nutlin-3 | multiple interactions | ISO | RGD:1353901 | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of AKR1C2 protein | CTD | PMID:38460933 |
Akr1c2 | Rat | ochratoxin A | decreases expression | ISO | RGD:1353901 | 6480464 | ochratoxin A results in decreased expression of AKR1C2 mRNA | CTD | PMID:19287073|PMID:32905824 |
Akr1c2 | Rat | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of AKR1C2 mRNA | CTD | PMID:30449730 |
Akr1c2 | Rat | octadecanoic acid | increases expression | ISO | RGD:1353901 | 6480464 | stearic acid results in increased expression of AKR1C2 mRNA | CTD | PMID:32347412 |
Akr1c2 | Rat | octyl gallate | decreases activity | ISO | RGD:1353901 | 6480464 | octyl gallate results in decreased activity of AKR1C2 protein | CTD | PMID:27163852 |
Akr1c2 | Rat | oxcarbazepine | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of oxcarbazepine | CTD | PMID:25063510 |
Akr1c2 | Rat | p-chloromercuribenzoic acid | increases expression | ISO | RGD:1353901 | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of AKR1C2 mRNA | CTD | PMID:26272509 |
Akr1c2 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | RGD:1353901 | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Akr1c2 | Rat | paclitaxel | increases response to substance | ISO | RGD:1353901 | 6480464 | AKR1C2 mRNA results in increased susceptibility to Paclitaxel | CTD | PMID:16322897 |
Akr1c2 | Rat | Panaxytriol | increases activity | ISO | RGD:1353901 | 6480464 | panaxytriol results in increased activity of AKR1C2 protein | CTD | PMID:18826220 |
Akr1c2 | Rat | Panaxytriol | multiple interactions | ISO | RGD:1353901 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [panaxytriol results in increased activity of AKR1C2 protein]; Ro 31-8220 inhibits more ... | CTD | PMID:18826220 |
Akr1c2 | Rat | para-Cresidine | increases expression | ISO | RGD:1353901 | 6480464 | cresidine results in increased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | paracetamol | decreases expression | ISO | RGD:1353901 | 6480464 | Acetaminophen results in decreased expression of AKR1C2 mRNA | CTD | PMID:29067470 |
Akr1c2 | Rat | Paraoxon-methyl | multiple interactions | ISO | RGD:1353901 | 6480464 | AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with methylparaoxon] | CTD | PMID:19800895 |
Akr1c2 | Rat | Paraoxon-methyl | increases expression | ISO | RGD:1353901 | 6480464 | methylparaoxon results in increased expression of AKR1C2 mRNA | CTD | PMID:19800895 |
Akr1c2 | Rat | parathion-methyl | multiple interactions | ISO | RGD:1353901 | 6480464 | AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with Methyl Parathion]; Benzo(a)pyrene promotes the reaction more ... | CTD | PMID:19800895 |
Akr1c2 | Rat | parathion-methyl | increases expression | ISO | RGD:1353901 | 6480464 | Methyl Parathion results in increased expression of AKR1C2 mRNA | CTD | PMID:19800895 |
Akr1c2 | Rat | parathion-methyl | increases activity | ISO | RGD:1353901 | 6480464 | Methyl Parathion results in increased activity of AKR1C2 protein | CTD | PMID:19800895 |
Akr1c2 | Rat | perfluorodecanoic acid | decreases expression | ISO | RGD:1353901 | 6480464 | perfluorodecanoic acid results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | perfluorooctanoic acid | decreases expression | ISO | RGD:1323510 | 6480464 | perfluorooctanoic acid results in decreased expression of AKR1C2 mRNA | CTD | PMID:17681415 |
Akr1c2 | Rat | phenethyl caffeate | decreases activity | ISO | RGD:1353901 | 6480464 | caffeic acid phenethyl ester results in decreased activity of AKR1C2 protein | CTD | PMID:27163852 |
Akr1c2 | Rat | phenobarbital | increases expression | ISO | RGD:1353901 | 6480464 | Phenobarbital results in increased expression of AKR1C2 protein | CTD | PMID:35881160 |
Akr1c2 | Rat | phenolphthalein | decreases activity | ISO | RGD:1353901 | 6480464 | Phenolphthalein results in decreased activity of AKR1C2 protein | CTD | PMID:12604236 |
Akr1c2 | Rat | Phenyl glycidyl ether | multiple interactions | ISO | RGD:1353901 | 6480464 | phenylglycidyl ether analog promotes the reaction [NFE2L2 protein results in increased expression of AKR1C2 mRNA] | CTD | PMID:21751775 |
Akr1c2 | Rat | phenylacetaldehyde | increases expression | ISO | RGD:1353901 | 6480464 | phenylacetaldehyde results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | phenylmercury acetate | increases expression | ISO | RGD:1353901 | 6480464 | Phenylmercuric Acetate results in increased expression of AKR1C2 mRNA | CTD | PMID:26272509 |
Akr1c2 | Rat | phenylmercury acetate | multiple interactions | ISO | RGD:1353901 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Akr1c2 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1323510 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Benzo(a)pyrene co-treated with Particulate Matter] results in increased expression of AKR1C21 more ... | CTD | PMID:18353537 |
Akr1c2 | Rat | phorbol 13-acetate 12-myristate | decreases expression | ISO | RGD:1353901 | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | pirinixic acid | decreases expression | ISO | RGD:1323510 | 6480464 | pirinixic acid results in decreased expression of AKR1C2 mRNA | CTD | PMID:18467677 |
Akr1c2 | Rat | pirinixic acid | increases expression | ISO | RGD:1323510 | 6480464 | pirinixic acid results in increased expression of AKR1C21 mRNA | CTD | PMID:20813756 |
Akr1c2 | Rat | pirinixic acid | multiple interactions | ISO | RGD:1323510 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of AKR1C2 mRNA] | CTD | PMID:18467677 |
Akr1c2 | Rat | potassium bromate | increases expression | EXP | | 6480464 | potassium bromate results in increased expression of AKR1C2 mRNA | CTD | PMID:23588252 |
Akr1c2 | Rat | progesterone | increases reduction | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased reduction of Progesterone | CTD | PMID:11158055|PMID:22245609|PMID:25463305 |
Akr1c2 | Rat | prostaglandin F2alpha | increases metabolic processing | ISO | RGD:1353901 | 6480464 | AKR1C2 protein results in increased metabolism of Dinoprost | CTD | PMID:8573067 |
Akr1c2 | Rat | quercetin | decreases expression | ISO | RGD:1353901 | 6480464 | Quercetin results in decreased expression of AKR1C2 mRNA | CTD | PMID:21632981 |
Akr1c2 | Rat | quinolin-8-ol | increases expression | ISO | RGD:1353901 | 6480464 | Oxyquinoline results in increased expression of AKR1C2 mRNA | CTD | PMID:21632981|PMID:26198647 |
Akr1c2 | Rat | reactive oxygen species | multiple interactions | ISO | RGD:1353901 | 6480464 | [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] which results in increased expression more ... | CTD | PMID:19320734 |
Akr1c2 | Rat | Ro 31-8220 | multiple interactions | ISO | RGD:1353901 | 6480464 | Ro 31-8220 inhibits the reaction [panaxytriol results in increased activity of AKR1C2 protein] | CTD | PMID:18826220 |
Akr1c2 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of AKR1C2 mRNA | CTD | PMID:28374803 |
Akr1c2 | Rat | salicylic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Salicylic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |
Akr1c2 | Rat | salicylic acid | increases expression | ISO | RGD:1353901 | 6480464 | Salicylic Acid results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | SB 431542 | multiple interactions | ISO | RGD:1353901 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Akr1c2 | Rat | silicon dioxide | increases secretion | ISO | RGD:1353901 | 6480464 | Silicon Dioxide analog results in increased secretion of AKR1C2 protein | CTD | PMID:25895662 |
Akr1c2 | Rat | silver atom | increases expression | ISO | RGD:1353901 | 6480464 | Silver results in increased expression of AKR1C2 mRNA | CTD | PMID:28959546 |
Akr1c2 | Rat | silver(0) | increases expression | ISO | RGD:1353901 | 6480464 | Silver results in increased expression of AKR1C2 mRNA | CTD | PMID:28959546 |
Akr1c2 | Rat | sodium arsenate | multiple interactions | ISO | RGD:1353901 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C2 more ... | CTD | PMID:32525701 |
Akr1c2 | Rat | sodium arsenite | increases expression | ISO | RGD:1353901 | 6480464 | sodium arsenite results in increased expression of AKR1C2 mRNA; sodium arsenite results in increased expression more ... | CTD | PMID:19696165|PMID:20886546|PMID:25493608|PMID:28595984|PMID:34032870|PMID:38568856 |
Akr1c2 | Rat | sodium arsenite | decreases expression | ISO | RGD:1353901 | 6480464 | sodium arsenite results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | sodium chloride | multiple interactions | ISO | RGD:1353901 | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of AKR1C2 protein; [Sodium Chloride co-treated more ... | CTD | PMID:38598786 |
Akr1c2 | Rat | sodium dodecyl sulfate | increases expression | ISO | RGD:1353901 | 6480464 | Sodium Dodecyl Sulfate results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | sulforaphane | increases expression | ISO | RGD:1353901 | 6480464 | sulforaphane results in increased expression of AKR1C2 mRNA | CTD | PMID:24383545|PMID:31746589 |
Akr1c2 | Rat | sulindac | decreases activity | ISO | RGD:1353901 | 6480464 | Sulindac results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |
Akr1c2 | Rat | tert-butyl hydroperoxide | increases expression | ISO | RGD:1353901 | 6480464 | tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA | CTD | PMID:12414654|PMID:15336504|PMID:23410634 |
Akr1c2 | Rat | testosterone | decreases expression | ISO | RGD:1353901 | 6480464 | Testosterone results in decreased expression of AKR1C2 mRNA | CTD | PMID:33359661 |
Akr1c2 | Rat | testosterone enanthate | affects expression | ISO | RGD:1353901 | 6480464 | testosterone enanthate affects the expression of AKR1C2 mRNA | CTD | PMID:17440010 |
Akr1c2 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AKR1C2 mRNA] | CTD | PMID:31150632 |
Akr1c2 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of AKR1C2 mRNA | CTD | PMID:31150632 |
Akr1c2 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of AKR1C2 mRNA | CTD | PMID:34492290 |
Akr1c2 | Rat | thiram | increases activity | ISO | RGD:1353901 | 6480464 | Thiram results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | thiram | decreases expression | ISO | RGD:1353901 | 6480464 | Thiram results in decreased expression of AKR1C2 mRNA | CTD | PMID:38568856 |
Akr1c2 | Rat | titanium dioxide | decreases phosphorylation | ISO | RGD:1353901 | 6480464 | titanium dioxide results in decreased phosphorylation of AKR1C2 protein | CTD | PMID:21439344 |
Akr1c2 | Rat | titanium dioxide | increases expression | ISO | RGD:1323510 | 6480464 | titanium dioxide results in increased expression of AKR1C21 mRNA | CTD | PMID:35295148 |
Akr1c2 | Rat | trans-isoeugenol | increases activity | ISO | RGD:1353901 | 6480464 | isoeugenol results in increased activity of AKR1C2 promoter | CTD | PMID:21195160 |
Akr1c2 | Rat | trans-isoeugenol | increases expression | ISO | RGD:1353901 | 6480464 | isoeugenol results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | Tributyltin oxide | increases expression | ISO | RGD:1353901 | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of AKR1C2 mRNA | CTD | PMID:26198647 |
Akr1c2 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of AKR1C2 mRNA | CTD | PMID:33387578 |
Akr1c2 | Rat | trichostatin A | increases expression | ISO | RGD:1353901 | 6480464 | trichostatin A results in increased expression of AKR1C2 mRNA | CTD | PMID:24935251|PMID:26272509 |
Akr1c2 | Rat | trichostatin A | multiple interactions | ISO | RGD:1353901 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Akr1c2 | Rat | tris(2-butoxyethyl) phosphate | decreases expression | ISO | RGD:1353901 | 6480464 | tris(2-butoxyethyl) phosphate results in decreased expression of AKR1C2 mRNA | CTD | PMID:29024780 |
Akr1c2 | Rat | tunicamycin | increases expression | ISO | RGD:1323510 | 6480464 | Tunicamycin results in increased expression of AKR1C21 mRNA | CTD | PMID:17127020 |
Akr1c2 | Rat | urethane | decreases expression | ISO | RGD:1353901 | 6480464 | Urethane results in decreased expression of AKR1C2 mRNA | CTD | PMID:28818685 |
Akr1c2 | Rat | ursodeoxycholic acid | multiple interactions | ISO | RGD:1353901 | 6480464 | Ursodeoxycholic Acid inhibits the reaction [[AKR1C2 protein co-treated with NADP] results in increased reduction of more ... | CTD | PMID:23261716 |
Akr1c2 | Rat | ursodeoxycholic acid | decreases activity | ISO | RGD:1353901 | 6480464 | Ursodeoxycholic Acid results in decreased activity of AKR1C2 protein | CTD | PMID:12604236|PMID:23261716|PMID:8573067 |
Akr1c2 | Rat | valproic acid | decreases methylation | ISO | RGD:1353901 | 6480464 | Valproic Acid results in decreased methylation of AKR1C2 gene | CTD | PMID:29154799 |
Akr1c2 | Rat | valproic acid | increases expression | ISO | RGD:1353901 | 6480464 | Valproic Acid results in increased expression of AKR1C2 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369 |
Akr1c2 | Rat | valproic acid | affects expression | ISO | RGD:1353901 | 6480464 | Valproic Acid affects the expression of AKR1C2 mRNA | CTD | PMID:25979313 |
Akr1c2 | Rat | valproic acid | multiple interactions | ISO | RGD:1353901 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA; [NOG protein co-treated more ... | CTD | PMID:17183730|PMID:27188386 |
Akr1c2 | Rat | vanillin | increases expression | ISO | RGD:1353901 | 6480464 | vanillin results in increased expression of AKR1C2 mRNA | CTD | PMID:20491607 |
Akr1c2 | Rat | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of AKR1C2 gene | CTD | PMID:31079544 |
Akr1c2 | Rat | vitamin E | increases expression | ISO | RGD:1353901 | 6480464 | Vitamin E results in increased expression of AKR1C2 mRNA | CTD | PMID:19244175 |
Akr1c2 | Rat | vorinostat | increases expression | ISO | RGD:1353901 | 6480464 | vorinostat results in increased expression of AKR1C2 mRNA | CTD | PMID:26272509 |
Akr1c2 | Rat | vorinostat | multiple interactions | ISO | RGD:1353901 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 |
Akr1c2 | Rat | zinc sulfate | increases expression | ISO | RGD:1353901 | 6480464 | Zinc Sulfate results in increased expression of AKR1C2 mRNA | CTD | PMID:16330358 |
Akr1c2 | Rat | zoledronic acid | decreases expression | ISO | RGD:1353901 | 6480464 | zoledronic acid results in decreased expression of AKR1C2 mRNA | CTD | PMID:25596134 |
Akr1c2 | Rat | zomepirac | decreases activity | ISO | RGD:1353901 | 6480464 | zomepirac results in decreased activity of AKR1C2 protein | CTD | PMID:19010312 |